Bradley Monk - Prima Biomed Insider

Prima Biomed Ltd -- USA Stock  

USD 0.012  0.002  20%

Member of the Clinical Advisory Board

We currently do not have informatin regarding Bradley Monk. This executive tanure with Prima Biomed Ltd is not currenlty determined.
  Executive Since 2014      
61 2 8315 7003  http://www.primabiomed.com.au

Management Efficiency

The company has return on total asset (ROA) of (15.25) % which means that it has lost $15.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (30.29) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 4.4 M in total debt with debt to equity ratio (D/E) of 21.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Prima Biomed Ltd has Current Ratio of 5.93 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Prima BioMed Ltd. engages in the research, development, and commercialization of medical biotechnology solutions in Australia. Prima Biomed Ltd (PRRUF) is traded on OTC Market in USA. It is located in Sydney, NSW and employs 31 people.

Did you try this?

Run Technical Analysis Now
   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
Hide  View All  NextLaunch Technical Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Prima Biomed Ltd to your portfolio

Top Management

Prima Biomed Leadership Team
Pete Meyers, Director, MBA
Russell Howard, Director, Ph.D
Tom Bloomfield, Executive
Larisa Chisholm, Executive
YueLing Wong, Chairman
Stuart Roberts, Executive
Frederic Triebel, Executive
Bradley Monk, Executive
Deanne Miller, Executive
Sharron Gargosky, Executive, Ph.D
Grant Chamberlain, Director
Lucy Turnbull, Chairman
Marc Voigt, CEO
Matthew Gregorowski, Executive

Stock Performance

Prima Biomed Performance Indicators